Updates on Clinical Trials in Systemic Lupus Erythematosus系统性红斑狼疮临床试验的更新CURRENT RHEUMATOLOGY REPORTSIF3.92021-07-014PREAI
Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cellsNATURE COMMUNICATIONSIF15.72020-06-0567OAAI
Serine/threonine phosphatase PP2A is essential for optima B cell functionJCI INSIGHTIF6.12020-03-1215OA
T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapyNATURE REVIEWS RHEUMATOLOGYIF32.72020-01-16197PREAI
PP2A enables IL-2 signaling by preserving IL-2Rβ chain expression during Treg developmentJCI INSIGHTIF6.12019-05-0224OA
Heparanase is expressed in adult human osteoarthritic cartilage and drives catabolic responses in primary chondrocytesOSTEOARTHRITIS AND CARTILAGEIF92018-08-016OAAI
INTERFERON-GAMMA CHALLENGE OF PBMC FROM PATIENTS WITH LUPUS NEPHRITIS IN REMISSION DECREASES SUPPRESSOR OF CYTOKINE SIGNALING 1 (SOCS1) AND REGULATORY T CELLS (TREGS) AND PROMOTES IMMUNE ACTIVATIONANNALS OF THE RHEUMATIC DISEASESIF20.62017-06-010OAAI
The Effect of the Presence of Fibromyalgia on Common Clinical Disease Activity Indices in Patients with Psoriatic Arthritis: A Cross-sectional StudyJOURNAL OF RHEUMATOLOGYIF3.42016-06-0190PREAI
Editorial: Molecules Balancing immunological Surveillance against Cancer and autoimmune diseasesFRONTIERS IN ONCOLOGYIF3.32016-04-120OAAI
FREQUENCY OF AXIAL SPONDYLOARTHROPATHY AMONG PATIENTS SUFFERING FROM FIBROMYALGIA. A MAGNETIC RESONANCE IMAGING STUDY APPLYING THE ASSESSMENT OF SPONDYLO-ARTHRITIS INTERNATIONAL SOCIETY CLASSIFICATION CRITERIAANNALS OF THE RHEUMATIC DISEASESIF20.62015-06-010PREAI
Novel approaches to the development of targeted therapeutic agents for systemic lupus erythematosus系统性红斑狼疮靶向治疗药物开发的新途径JOURNAL OF AUTOIMMUNITYIF72014-11-0139PREAI
A novel tolerogenic peptide, hCDR1, for the specific treatment of systemic lupus erythematosusAUTOIMMUNITY REVIEWSIF8.32010-11-0125PRE
Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptideJOURNAL OF AUTOIMMUNITYIF72010-03-0126PREAI
A New Model of Induced Experimental Systemic Lupus Erythematosus (SLE) in Pigs and Its Amelioration by Treatment with a Tolerogenic PeptideJOURNAL OF CLINICAL IMMUNOLOGYIF5.72009-09-1614PREAI
Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): Immunomodulation of gene expressionJOURNAL OF AUTOIMMUNITYIF72009-08-0151PREAI
The tolerogenic peptide hCDR1 downregulates pathogenic cytokines and apoptosis and upregulates immunosuppressive molecules and regulatory T cells in peripheral blood mononuclear cells of lupus patientsHUMAN IMMUNOLOGYIF2.22009-03-0129PREAI